Sequential versus concurrent chemotherapy for adjuvant breast cancer: does dose intensity matter?

Br J Cancer. 2017 Jul 11;117(2):157-300. doi: 10.1038/bjc.2017.176. Epub 2017 Jun 22.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Breast
  • Breast Neoplasms*
  • Chemotherapy, Adjuvant
  • Docetaxel*
  • Epirubicin
  • Humans

Substances

  • Docetaxel
  • Epirubicin